Clinical Trials Browser

Polycystic Ovary Syndrome × Metformin × 1 year × Clear all

NCT07459595 2026-03-10

Metformin Versus Myo-inositol in the Management of Polycystic Ovarian Disease: A Comparative Study

Phase 1 Not yet recruiting

Polycystic Ovary Syndrome

NCT05965908 2026-03-06

Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

Phase 3 Completed

Polycystic Ovary Syndrome

NCT03905941 2026-02-23

SHK002

Phase EARLY_PHASE1 Withdrawn

Polycystic Ovary Syndrome

NCT07399535 2026-02-10

PCOS

Phase 1 Recruiting

Infertility, Metabolic Diseases, Polycystic Ovary Syndrome

NCT05767515 2026-02-09

PCOS

Phase NA Completed

Infertility, Female, Polycystic Ovary Syndrome

NCT07387679 2026-02-04

Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity

Phase NA Completed

Polycystic Ovary Syndrome

NCT07380841 2026-02-02

PCOS-COMBO (9)

Phase NA Completed

Insulin Resistance, Polycystic Ovary Syndrome, Weight Loss, Metabolic Syndrome

NCT07323589 2026-01-07

Impact of Myo-Inositol Alone vs Myo-Inositol Plus Metformin on Conception, Adherence, and Tolerability in PCOS

Phase 3 Completed

Polycystic Ovary Syndrome

NCT05802212 2025-11-25

Effect of Metformin on Patients With Polycystic Ovary Syndrome

Phase NA Completed

Polycystic Ovary Syndrome

NCT06479434 2025-10-07

Serum Biomarker Levels Improvement in Poly Cystic Ovarian Syndrome: Impact of Metformin Compared to Healthy Controls

Phase NA Completed

Insulin Resistance, Polycystic Ovary Syndrome

NCT05680805 2025-09-19

Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS

Phase 4 Active not recruiting

Polycystic Ovary Syndrome

NCT07120815 2025-08-13

MET-PCOS

Phase 3 Not yet recruiting

Polycystic Ovary Syndrome

NCT02500147 2025-07-02

Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)

Phase 4 Terminated

3 enrolled 5 charts

Acne Vulgaris, Amenorrhea, Hirsutism, Polycystic Ovary Syndrome, Metabolic Syndrome, Dyslipidemias, Non-alcoholic Fatty Liver Disease

NCT05966792 2025-06-11

SGLT2 Inhibitors in Treating Patients With PCOS

Phase NA Enrolling by invitation

Polycystic Ovary Syndrome

NCT06742710 2025-05-29

LITOP

Phase 4 Recruiting

Infertility, Obesity, Polycystic Ovary Syndrome

NCT06140108 2025-05-14

Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity

Phase 2/3 Completed

Polycystic Ovary Syndrome, Weight Gain

NCT06896981 2025-04-02

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

Phase 2/3 Recruiting

Obesity, Polycystic Ovary Syndrome

NCT02521753 2025-04-01

OMgObPCOS

Phase NA Terminated

Obesity, Polycystic Ovary Syndrome